Consumer Health: Blood donation saves lives; are you a donor?
January is National Blood Donor Month, which makes this a good time to become a blood donor. Nearly 16 million blood components are transfused each year in the U.S., according to the American Red Cross. Daily needs include 29,000 units of red blood cells, 5,000 units of platelets and 6,500 units of plasma. People need a blood transfusion for many reasons. Some may need blood during surgery. Others depend on it after an accident or because they… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 19, 2022 Category: Databases & Libraries Source Type: news
Is it safe to use lower blood counts as a trigger for blood transfusion?
Tuesday, January 4, 2022 (Source: Cochrane News and Events)
Source: Cochrane News and Events - January 4, 2022 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Mayo Clinic Q & amp;A podcast: Urgent need for blood donation
Blood donations typically drop off around the holidays, making National Blood Donor Month in January and important time to share the message about saving lives by giving blood. The COVID-19 pandemic also has affected blood donations. "The COVID-19 pandemic has really had an adverse effect on us recruiting and collecting blood donors in general," says Dr. Justin Juskewitch, associate medical director of Mayo Clinic Blood Donor Services. Millions of people need blood transfusions each year.… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - January 3, 2022 Category: Hospital Management Source Type: news
Clusterin: Hints Of New Hope For Aging And Alzheimer ’s
A recent study has found that blood transfusions from highly active mice into sedentary mice boosted brain function in the sedentary recipients. This discovery may mark a significant step in uncovering treatments to slow the progression of neurodegenerative diseases like Alzheimer ’s or Dementia. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 17, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple Myeloma
The objective responsive rate observed in this study suggests a potential benefit for many patients with triple-class exposed disease with an off-the-shelf therapy.”As of September 2021, 165 patients were treated with teclistamab at the SC 1.5 mg/kg dose across both Phase 1 and Phase 2 of MajesTEC-1.1 The primary objectives of the MajesTEC-1 Phase 1 study (NCT03145181) were to identify the recommended SC RP2D (part 1) and characterize the safety and tolerability of teclistamab at the RP2D (part 2). The primary objective of the MajesTEC-1 Phase 2 study (NCT04557098) was to evaluate the efficacy of teclistamab at the RP2D,...
Source: Johnson and Johnson - December 13, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma
ATLANTA, Ga., December 11, 2021– The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the MonumenTAL-1 Phase 1 first-in-human dose-escalation study of talquetamab (NCT03399799). Talquetamab is the only investigational off-the-shelf T cell redirecting bispecific antibody in clinical development targeting both GPRC5D, a novel multiple myeloma target, and CD3 on T cells.[1] Results from the study show that no new safety signals were observed with longer follow-up.1 Heavily pretreated patients with multiple myeloma treated with talquetamab at the recommended subcutaneous (SC) Pha...
Source: Johnson and Johnson - December 11, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
New Clinical and Real-World Data Support Use of DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma
ATLANTA, Ga., December 11, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX® (daratumumab)-based regimens may be able to achieve, including a potential survival benefit for DARZALEX® in combination with lenalidomide and dexamethasone (Rd). Updated data from the randomized Phase 2 GRIFFIN study in transplant-eligible patients and real-world evidence in transplant-ineligible patients were presented at the American Society of Hematology (ASH) 2021 Annual Meeting. Data from the GRIFFIN study will also be featured...
Source: Johnson and Johnson - December 11, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Infected blood inquiry: Doctor's 1983 Aids statement 'unfortunate'
Dr Anthony Napier said there was no link between Aids and blood transfusions in a newspaper article. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 1, 2021 Category: Consumer Health News Source Type: news
Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Sickle Cell Disease 101: A Chat with Sickle Cell Warrior Nicklaine Paul
More than 100,000 people have sickle cell disease in the U.S. and many require regular blood transfusions throughout their lifetime. Blood transfusions help manage the severe pain and long-term...
{This is a content summary only. Click the blog post title to continue reading this post, share your comments, browse the blog and more!} (Source: Red Cross Chat)
Source: Red Cross Chat - November 2, 2021 Category: International Medicine & Public Health Authors: American Red Cross Tags: Blood american red cross blood donation blood donor blood transfusions sickle cell sickle cell advocacy sickle cell disease Sickle cell warrior Source Type: news
World ’ s Deadliest Malaria Parasite Dominance in Africa Could Be Over – Experts
A child health consultation at Obunga Dispensary in Homa Bay, one of the eight counties participating in the malaria vaccine pilot program. Credit: Joyce Chimbi/IPSBy Joyce ChimbiNairobi, Kenya, Oct 25 2021 (IPS) One morning in 2016, Lillian Nekesa’s 3-year-old woke up with flu-like classic symptoms of malaria. This was not Kevin’s first encounter with the killer disease.
Kevin was nonetheless not immediately rushed to Busia County Referral Hospital for advanced treatment in keeping with his severe symptoms.
Nekesa rushed him to a village dispensary because the referral hospital is an hour’s walk away fr...
Source: IPS Inter Press Service - Health - October 25, 2021 Category: International Medicine & Public Health Authors: Joyce Chimbi Tags: Africa COVID-19 Development & Aid Featured Headlines Health Human Rights Inequity TerraViva United Nations #Health #MalariaVaccine Kenya Source Type: news
Troubling connections between epilepsy, health problems during childbirth
The risk of severe maternal morbidity — serious problems such as needing blood transfusions, hysterectomies or ventilators — are found to be steep, researchers say. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 16, 2021 Category: Consumer Health News Authors: Erin Blakemore Source Type: news
Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities
New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results
RARITAN, N.J., Sept. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Ortho Clinical Diagnostics (NASDAQ: OCDX), on... Diagnostics, Product Launch Ortho Clinical Diagnostics, Immediate Spin Crossmatch, blood transfusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news
Uganda: Govt Rejects Sex Workers, Drunks As Blood Donors
[Monitor] Uganda Blood Transfusion Services has said it no longer accepts blood from drunkards and donors with multiple sexual partners to avoid incurring losses. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 21, 2021 Category: African Health Source Type: news
